Just a few things that I found interesting:
— Timothy McBride (@mcbridetd) May 16, 2015
— Larry Levitt (@larry_levitt) May 14, 2015
Care costs are growing at a rate slower than nominal economic growth in every category but prescriptions. Hep-C is driving a good chunk of the prescription spending surge BUT the new Hep-C drugs are now significantly discounted from headline rates and they should reduce medical expenditures in the out-years.